Advertisement

Topics

MEDINET Co., Ltd. and MaxCyte, Inc. Company Profile

22:15 EDT 18th March 2019 | BioPortfolio

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technologies and knowhow in: cell processing and culturing, quality control, and facility management with respect to the immuno-cell therapy. MEDINET has extensive experience in autologous cell processing; with nearly 15,000 cancer patients treated in actual clinical practice through more than 124,000 cell therapy manufacturing processes. MEDINET continues to invest in R&D to improve cell processing technologies in an effort to increase efficacy in collaborative clinical studies with university hospitals and medical institutions. MEDINET went public in October, 2003 on the MOTHERS, Tokyo Stock Exchange.


News Articles [33 Associated News Articles listed on BioPortfolio]

MaxCyte updates on plans to simplify share structure

MaxCyte currently has two classes of shares: unrestricted and Regulation S restricted

MaxCyte starts dosing in Phase I trial of MCY-M11

MaxCyte has dosed the first patient in a Phase I clinical trial to evaluate the safety and effectiveness of intraperitoneal...Read More... The post MaxCyte starts dosing in Phase I trial of MCY-M11 ap...

CRISPR and MaxCyte sign licensing deal for cancer therapies

Swiss gene editing firm CRISPR Therapeutics has signed a non-exclusive commercial licence agreement with US-based drug maker MaxCyte for the...Read More... The post CRISPR and MaxCyte sign licensing d...

Precision, MaxCyte Enter Clinical Agreement

Allows Precision to use MaxCyte's Flow Electroporation® technologies to robustly deliver ARCUS genome-editing technology

MaxCyte begins dosing in phase I solid tumors clinical trial

The study is designed to evaluate MCY-M11, a mesothelin targeting CAR, in individuals with relapsed/refractory ovarian cancer and peritoneal mesothelioma. MaxCyte CEO Doug Doerfler said: “The in...

CRISPR, MaxCyte expand partnership into immuno-oncology

The companies have entered into a non-exclusive commercial license agreement that will allow CRISPR Therapeutics to deploy MaxCyte’s Flow Electroporation Technology to develop CRISPR/Cas9-based ther...

MaxCyte on track to start first-ever clinical trial before the end of the year

The phase I clinical study will evaluate the safety of MaxCyte's MCY-M11 chimeric antigen receptor in people with relapsed or difficult-to-treat ovarian cancer and peritoneal mesothelioma

MaxCyte and Kite Enter Multi-Drug CAR-T Technology Deal

Gaithersburg, Maryland – 01 March 2019: MaxCyte (LSE: MXCT, MXCS), the global cell-based medicines and life sciences company, announced today that it has expanded its re...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technol...

MaxCyte, Inc.

MaxCyte specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of innovative therapeutic products. Drawing on its cell the...

MaxCyte, Inc

MaxCyte is a clinical-stage cell therapeutics company with a growing pipeline of proprietary and partnered drug candidates. Programs in development are based on MaxCyte's platform technology which bre...

More Information about "MEDINET Co., Ltd. and MaxCyte, Inc." on BioPortfolio

We have published hundreds of MEDINET Co., Ltd. and MaxCyte, Inc. news stories on BioPortfolio along with dozens of MEDINET Co., Ltd. and MaxCyte, Inc. Clinical Trials and PubMed Articles about MEDINET Co., Ltd. and MaxCyte, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MEDINET Co., Ltd. and MaxCyte, Inc. Companies in our database. You can also find out about relevant MEDINET Co., Ltd. and MaxCyte, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record